Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes

Key Clinical Message Paroxysmal nocturnal hemoglobinuria is a rare disease with the incidence ranging from 0.08 to 0.57 per 100,000 person‐years. Up to 25% of cases in women are detected during pregnancy. We report two cases of successful pregnancy outcomes in patients treated with eculizumab, point...

詳細記述

書誌詳細
出版年:Clinical Case Reports
主要な著者: Jovanka Ilic, Borislava Pujic, Branislava Jakovljevic, Borivoj Sekulic, Danijela Agic, Amir El Farra, Branimir Micanovic, Tihomir Vejnovic, Ivana Urosevic, Aleksandar Savic
フォーマット: 論文
言語:英語
出版事項: Wiley 2024-05-01
主題:
eculizumab
paroxysmal nocturnal hemoglobinuria
PNH
pregnancy
オンライン･アクセス:https://doi.org/10.1002/ccr3.8900
その他の書誌記述
要約:Key Clinical Message Paroxysmal nocturnal hemoglobinuria is a rare disease with the incidence ranging from 0.08 to 0.57 per 100,000 person‐years. Up to 25% of cases in women are detected during pregnancy. We report two cases of successful pregnancy outcomes in patients treated with eculizumab, pointing out the importance of interdisciplinary approach in these high‐risk pregnancies.
ISSN:2050-0904

類似資料